Anda, China Health Recent News, Events and Opinion on Allvoices
Front Page

Just In Anda Health News

 
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2014-07-09 18:18:18 -0700 | health-news

US Food and Drug Administration (FDA) seeking approval to market Dalfampridine Extended-release Tablets, 10 mg. Acorda Therapeutics' Ampyra, which is indicated as a treatment to improve walking in patients with multiple sclerosis. Acorda Therapeutics, Inc. filed suit against Actavis on...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Daily News & Analysis

Anda :: China | updated 2014-07-08 05:25:51 -0700 | health-news

Indian pharma, although these enforcements are not country specific but more on account of "cultural differences", said a report by global credit rating agency Crisil.  The companies have little choice but to invest in bringing compliance processes up to speed,...
Credibility  
Views: 1   News Stories: 0
Blog Posts: 0 0 0 0
 
 
 
Source: Drug and Device Law

Anda :: China | updated 2014-06-27 10:39:10 -0700 | health-news

Failure to communicate claims magically timed Dear Doctor letters are preempted.   They would violate the duty of sameness.   Darvocet , slip op. at 17-18. NDA, and there's no switching between the two.   Darvocet , slip op. at...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2014-06-23 11:18:06 -0700 | health-news

The deal designates IGI Laboratories as the developer, manufacturer and owner of a generic topical pharmaceutical drug product, which will be licensed, marketed and distributed in the US by Impax's generics division Global Pharmaceuticals...IGI Laboratories president and CEO Jason Grenfell-Gardner...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2014-06-17 08:43:01 -0700 | health-news

Codeine Sulfate Tablets USP, a schedule II controlled substance, 15mg, 30mg and 60mg, the therapeutic equivalent to the reference listed drug, Codeine Sulfate Tablets USP 15mg, 30mg and 60mg, of Roxane Laboratories. According to IMS, for the year ended April...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2014-06-09 23:26:54 -0700 | health-news

The injection is indicated in hemophilia patients for short-term use (two to eight days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. Manufacturing of tranexamic acid injection will be carried out...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2014-06-03 08:47:34 -0700 | health-news

US Food and Drug Administration (FDA) for Celecoxib Capsules, 50mg, 100mg, 200mg and 400mg. The drug is the generic version of Celebrex, which is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and...
Credibility  
Views: 0   News Stories: 0
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2011-09-13 09:07:32 -0700 | technology-news

Fondaparinux Sodium Injection is the generic version of GlaxoSmithKline's (GSK) Arixtra which is indicated as a treatment for acute deep vein thrombosis when administered in conjunction with warfarin sodium. The approved doses of the injection include 2.5mg/ 0.5ml, 5.0mg/ 0.4ml,...
Credibility  
Views: 60   News Stories: 1
Blog Posts: 0 0 0 0
 
 
Source: Pharmaceutical Industry News

Anda :: China | updated 2011-04-23 12:50:44 -0700 | technology-news

US Food & Drug Administration (FDA) for calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment, generic forms of Taclonex Ointment. Taclonex ointment is indicated to topically treat psoriasis vulgaris in adults 18 years of age and older.
Credibility  
Views: 22   News Stories: 1
Blog Posts: 0 0 0 0
 

Build Your Allvoices Brand. Gain Influence. Make Money.

Join the Build Your Allvoices Brand Incentive Program



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.